Grace Therapeutics, Inc. (GRCE)

NASDAQ: GRCE · Real-Time Price · USD

Compare

3.600

+0.120 (3.45%)

At close: Feb 6, 2026, 4:00 PM EST

3.590

-0.010 (-0.28%)

After-hours: Feb 6, 2026, 7:31 PM EST

Grace Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	16.86	22.13	23.01	27.88	30.34	50.94
Short-Term Investments	-	-	-	0.02	13.32	9.79
Cash & Short-Term Investments	16.86	22.13	23.01	27.89	43.66	60.73
Cash Growth	11.15%	-3.79%	-17.52%	-36.12%	-28.11%	326.48%
Other Receivables	0.02	0.13	0.72	0.8	0.55	0.53
Receivables	0.02	0.13	0.72	0.8	0.55	0.53
Prepaid Expenses	0.42	0.45	0.28	0.6	0.72	0.34
Other Current Assets	-	-	-	-	0.35	0.77
Total Current Assets	17.3	22.71	24.01	29.29	45.28	62.37
Property, Plant & Equipment	0.01	0	0.01	0.57	0.57	0.09
Goodwill	8.14	8.14	8.14	8.14	12.96	-
Other Intangible Assets	41.13	41.14	41.15	41.13	69.81	-
Total Assets	66.58	71.99	73.3	79.12	128.62	62.46
Accounts Payable	0.46	0.6	1.01	1.24	1.68	0.12
Accrued Expenses	0.79	1.33	0.68	2.09	1.48	1.38
Current Portion of Leases	-	-	-	0.08	0.1	0.09
Total Current Liabilities	1.25	1.93	1.68	3.41	3.26	1.58
Long-Term Leases	-	-	-	0.41	0.19	-
Long-Term Deferred Tax Liabilities	2.31	2.31	5.51	7.35	16.89	-
Other Long-Term Liabilities	0.2	1.14	4.36	-	0.01	5.22
Total Liabilities	3.76	5.38	11.56	11.17	20.35	6.8
Common Stock	0	0	0	258.29	257.99	197.19
Additional Paid-In Capital	293.84	293.33	278.9	13.97	12.15	10.82
Retained Earnings	-224.99	-220.69	-211.12	-198.27	-155.84	-146.02
Comprehensive Income & Other	-6.04	-6.04	-6.04	-6.04	-6.04	-6.33
Shareholders' Equity	62.82	66.61	61.74	67.96	108.27	55.66
Total Liabilities & Equity	66.58	71.99	73.3	79.12	128.62	62.46
Total Debt	-	-	-	0.49	0.3	0.09
Net Cash (Debt)	16.86	22.13	23.01	27.41	43.37	60.65
Net Cash Growth	11.15%	-3.79%	-16.05%	-36.80%	-28.49%	330.32%
Net Cash Per Share	1.18	1.83	2.41	3.69	7.06	24.54
Filing Date Shares Outstanding	14.13	13.83	9.4	7.44	7.38	4.34
Total Common Shares Outstanding	14.13	13.72	9.4	7.44	7.38	4.34
Working Capital	16.05	20.78	22.33	25.88	42.02	60.79
Book Value Per Share	4.45	4.86	6.57	9.14	14.67	12.82
Tangible Book Value	13.55	17.33	12.46	18.69	25.5	55.66
Tangible Book Value Per Share	0.96	1.26	1.33	2.51	3.45	12.82
Machinery	-	0.01	0.61	0.67	0.7	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q